Marked improvement in delirium with ramelteon: Five case reports

Psychogeriatrics

Volumn 12, Issue 4, 2012, Pages 259-262

  Furuya, Motohide ^a   Miyaoka, Tsuyoshi ^a   Yasuda, Hideaki ^a   Yamashita, Satoko ^a   Tanaka, Ippei ^a   Otsuka, Shoko ^a   Wake, Rei ^a   Horiguchi, Jun ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Circadian rhythm; Delirium; Melatonin; Ramelteon

Indexed keywords

MIDAZOLAM; QUETIAPINE; RAMELTEON; RISPERIDONE; TIAPRIDE; ZOTEPINE;

AGED; ARTICLE; BEDTIME DOSAGE; CASE REPORT; CIRCADIAN RHYTHM; CONTINUOUS INFUSION; DELIRIUM; FEMALE; HUMAN; LETHARGY; MALE; MENTAL HEALTH; POSTOPERATIVE DELIRIUM; PRIORITY JOURNAL; SLEEP; SLEEP QUALITY; SLEEP WAKING CYCLE; VISUAL HALLUCINATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CIRCADIAN RHYTHM; DELIRIUM; FEMALE; HUMANS; INDENES; MALE; MELATONIN; TREATMENT OUTCOME;

EID: 84871836548     PISSN: 13463500     EISSN: 14798301     Source Type: Journal    
DOI: 10.1111/j.1479-8301.2012.00422.x     Document Type: Article

References (17)

1. Inouye SK. Delirium in older persons. N Engl J Med 2006; 354: 1157-1165.
2. Schorl JD, Levkoff SE, Lipsitz LA etal. Risk factors for delirium in hospitalized elderly. JAMA 1992; 267: 827-831.
3. George J, Bleasdale S, Singleton SJ. Causes and prognosis of delirium in elderly patients admitted to a distinct general hospital. Age Ageing 1997; 26: 423-427.
4. Pandi-Perumal SR, Srinivasan V, Spence DW etal. Ramelton: a review of its therapeutic potential in sleep disorders. Adv Ther 2009; 26: 613-626.
5. Al-Aama T, Brymer C, Gutmanis I etal. Melatonin decreases delirium in elderly patients: a randomized, placebo-controlled trial. Int J Geriatr Psychiatry 2011; 26: 687-694.
6. Kimura R, Mori K, Kumazaki H etal. Treatment of delirium with ramelteon: initial experience in three patients. Gen Hosp Psychiatry 2011; 33: 407-409.
7. McCurry SM, Pike KC, Vittelo MV etal. Factors associated with concordance and variability of sleep quality in persons with Alzheimer's disease and their caregivers. Sleep 2008; 31: 741-748.
8. Lipowski ZJ. Delirium: Acute Confusional States. New York: Oxford University Press, 1990; 442-478.
9. Turek FW, Gillette MU. Melatonin, sleep, and circadian rhythm: rationale for the development of specific melatonin agonist. Sleep Med 2004; 5: 523-532.
10. 2 receptor agonist. Neuropharmacology 2005; 48: 301-310.
11. Simpson D, Curran MP. Ramelteon: a review of its use in insomnia. Drugs 2008; 68: 1901-1919.
12. Hshieh TT, Fong TG, Marcantonio ER, Inouye SK. Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence. J Gerontol A Biol Sci Med Sci 2008; 63: 764-772.
13. Van Munster BC, Korevaar JC, Zwinderma AH etal. Time-course of cytokines during delirium in elderly patients with hip fractures. J Am Geriatr Soc 2008; 56: 1704-1709.
14. Iguchi H, Kato K, Ibayashi H. Age-dependent reduction in serum melatonin concentrations in healthy human subjects. J Clin Endocrinol Metab 1982; 55: 27-29.
15. Swaab DF, Van Someren EJ, Zhou JN etal. Biological rhythms in the human life cycle and their relationship to functional changes in the suprachiasmatic nucleus. Prog Brain Res 1996; 111: 349-368.
16. Kosaka M, Kanemura T, Taniguchi M etal. Efficacy and tolerability of ramelteon in a double-blind, placebo-controlled, crossover study in Japanese patients with chronic primary insomnia. Expert Rev Neurother 2011; 11: 1389-1397.
17. Balan S, Leibovitz A, Zila SO etal. The relation between the clinical subtypes of delirium and the urinary level of 6-SMT. J Neuropsychiatry Clin Neurosci 2003; 15: 363-366.